UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases

Journal of hepatology, 2013-09, Vol.59 (3), p.621-625

2013

Volltextzugriff (PDF)

Therapeutic Targets in Polycystic Liver Disease

Current drug targets, 2017-01, Vol.18 (8), p.950

2017

Volltextzugriff (PDF)

Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis

Hepatology (Baltimore, Md.), 2018-06, Vol.67 (6), p.2462-2464

2018

Volltextzugriff (PDF)

Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling

American journal of physiology: Gastrointestinal and liver physiology, 2013-06, Vol.304 (11), p.G1013-G1024

2013

Volltextzugriff (PDF)

Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target

Hepatology (Baltimore, Md.), 2018-03, Vol.67 (3), p.1088-1108

2018

Volltextzugriff (PDF)

Cholangiocyte primary cilia in liver health and disease

Developmental dynamics, 2008-08, Vol.237 (8), p.2007-2012

2008

Volltextzugriff (PDF)

Characterization of PKD Protein-Positive Exosome-Like Vesicles

Journal of the American Society of Nephrology, 2009-02, Vol.20 (2), p.278-288

2009

Volltextzugriff (PDF)

Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease

The American journal of pathology, 2018-04, Vol.188 (4), p.981-994

2018

Volltextzugriff (PDF)

Octreotide Inhibits Hepatic Cystogenesis in a Rodent Model of Polycystic Liver Disease by Reducing Cholangiocyte Adenosine 3′,5′-Cyclic Monophosphate

Gastroenterology (New York, N.Y. 1943), 2007-03, Vol.132 (3), p.1104-1116

2007

Volltextzugriff (PDF)

Somatostatin analog therapy for severe polycystic liver disease: results after 2 years

Nephrology, dialysis, transplantation, 2012-09, Vol.27 (9), p.3532-3539

2012

Volltextzugriff (PDF)

Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion

Proceedings of the National Academy of Sciences - PNAS, 2007-11, Vol.104 (48), p.19138-19143

2007

Volltextzugriff (PDF)

HDAC6 Is Overexpressed in Cystic Cholangiocytes and Its Inhibition Reduces Cystogenesis

The American journal of pathology, 2014-03, Vol.184 (3), p.600-608

2014

Volltextzugriff (PDF)

Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

Journal of the American Society of Nephrology, 2010-06, Vol.21 (6), p.1052-1061

2010

Volltextzugriff (PDF)

The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)

Hepatology (Baltimore, Md.), 2009-01, Vol.49 (1), p.160-174

2009

Volltextzugriff (PDF)

TGR5 in the Cholangiociliopathies

Digestive diseases (Basel), 2015-01, Vol.33 (3), p.420-425

2015

Volltextzugriff (PDF)

Significant disparities in allergy prevalence and microbiota between the young people in Finnish and Russian Karelia

Clinical and experimental allergy, 2017-05, Vol.47 (5), p.665-674

2017

Volltextzugriff (PDF)

Activation of Trpv4 Reduces the Hyperproliferative Phenotype of Cystic Cholangiocytes From an Animal Model of ARPKD

Gastroenterology (New York, N.Y. 1943), 2010-07, Vol.139 (1), p.304-314.e2

2010

Volltextzugriff (PDF)

Polycystic Liver Disease: Advances in Understanding and Treatment

Annual review of pathology, 2022-01, Vol.17, p.251

2022

Volltextzugriff (PDF)

Autophagy promotes hepatic cystogenesis in polycystic liver disease by depletion of cholangiocyte ciliogenic proteins

Hepatology (Baltimore, Md.), 2022-05, Vol.75 (5), p.1110-1122

2022

Volltextzugriff (PDF)

Inhibition of Cdc25A Suppresses Hepato-renal Cystogenesis in Rodent Models of Polycystic Kidney and Liver Disease

Gastroenterology (New York, N.Y. 1943), 2012-03, Vol.142 (3), p.622-633.e4

2012

Volltextzugriff (PDF)

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

Journal of hepatology, 2015-10, Vol.63 (4), p.952-961

2015

Volltextzugriff (PDF)

Polycystic Liver Disease: The Benefits of Targeting cAMP

Clinical gastroenterology and hepatology, 2016-07, Vol.14 (7), p.1031-1034

2016

Volltextzugriff (PDF)

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

Gut, 2014-10, Vol.63 (10), p.1658-1667

2014

Volltextzugriff (PDF)

Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia

Human molecular genetics, 2003-10, Vol.12 (20), p.2703-2710

2003

Volltextzugriff (PDF)

Revisiting the conducting of measurements from the board of International Space Station by decimeter synthetic aperture radar system

Journal of physics. Conference series, 2020-09, Vol.1632 (1), p.12015

2020

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(30)
Russisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases

Therapeutic Targets in Polycystic Liver Disease

Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis

Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling

Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target

Cholangiocyte primary cilia in liver health and disease

Characterization of PKD Protein-Positive Exosome-Like Vesicles

Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease

Octreotide Inhibits Hepatic Cystogenesis in a Rodent Model of Polycystic Liver Disease by Reducing Cholangiocyte Adenosine 3′,5′-Cyclic Monophosphate

Somatostatin analog therapy for severe polycystic liver disease: results after 2 years

Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion

HDAC6 Is Overexpressed in Cystic Cholangiocytes and Its Inhibition Reduces Cystogenesis

Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)

TGR5 in the Cholangiociliopathies

Significant disparities in allergy prevalence and microbiota between the young people in Finnish and Russian Karelia

Activation of Trpv4 Reduces the Hyperproliferative Phenotype of Cystic Cholangiocytes From an Animal Model of ARPKD

Polycystic Liver Disease: Advances in Understanding and Treatment

Autophagy promotes hepatic cystogenesis in polycystic liver disease by depletion of cholangiocyte ciliogenic proteins

Inhibition of Cdc25A Suppresses Hepato-renal Cystogenesis in Rodent Models of Polycystic Kidney and Liver Disease

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

Polycystic Liver Disease: The Benefits of Targeting cAMP

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia

Revisiting the conducting of measurements from the board of International Space Station by decimeter synthetic aperture radar system

Suchergebnisse filtern